Livforsakringsbolaget Skandia Omsesidigt Acquires Shares of 98,000 Option Care Health, Inc. $OPCH

Key Points

• Livforsakringsbolaget Skandia Omsesidigt invested $3.18 million in Option Care Health, acquiring 98,000 shares, bringing its total ownership to 0.06% as of its latest SEC filing.
• Option Care Health reported a quarterly revenue of $1.42 billion, exceeding analyst expectations and a year-over-year growth of 15.4%, along with an EPS of $0.41.
• The consensus rating for Option Care Health's stock is a "Moderate Buy" with eight analysts giving it a Buy rating and an average target price of $35.75.

Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 98,000 shares of the company's stock, valued at approximately $3,182,000. Livforsakringsbolaget Skandia Omsesidigt owned 0.06% of Option Care Health at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Compass Wealth Management LLC boosted its holdings in Option Care Health by 8.9% during the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock valued at $5,804,000 after acquiring an additional 13,600 shares during the period. Bessemer Group Inc. lifted its stake in shares of Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Option Care Health by 1.4% in the first quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock valued at $16,981,000 after buying an additional 6,616 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Option Care Health by 25.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after buying an additional 1,691 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Option Care Health by 307.1% in the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after buying an additional 2,408 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Activity at Option Care Health

In related news, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was bought at an average cost of $27.15 per share, with a total value of $977,400.00. Following the acquisition, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 59,411 shares of company stock valued at $1,627,576 over the last quarter. Corporate insiders own 0.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Barrington Research reiterated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.70 during midday trading on Tuesday, reaching $27.97. The company had a trading volume of 1,541,238 shares, compared to its average volume of 1,855,500. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.54 billion, a price-to-earnings ratio of 22.28, a price-to-earnings-growth ratio of 1.72 and a beta of 0.83. The stock has a fifty day simple moving average of $28.79 and a 200 day simple moving average of $31.17. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.